ArticleBMJ public health2025
Applying a diffusion of innovations framework to characterise diffusion groups and more effectively reach late adopters: a cross-sectional study on COVID-19 vaccinations in Canada in late 2021.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gender disparities in the adoption of improved management practices for soybean cultivation in North East Nigeria.Journal of agriculture and food research · 2025Article
- Before the wave: Exploring early perspectives on COVID-19 self-testing among African Americans in Eastern North Carolina.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rogers' diffusion of innovation theory suggests innovations are adopted in stages by different groups (innovators/early adopters, early majority, late majority and late adopters). In healthcare, this could mean that there is the potential to worsen health disparities as later groups tend to also face more social and structural barriers. Determining the unique sociodemographic characteristics, beliefs and attitudes of those in each diffusion category could be useful for theorising how to reach later groups more effectively. Methods: Using a cross-sectional survey among Canadian adults in late 2021, we assigned respondents to diffusion groups based on when they received their first dose, relative to others within their age group in accordance with Rogers' model (ie, cut points: 16%, 50%, 84% with 100% being all those vaccinated within the age group). Participants answered questions about their COVID-19 vaccinations and questions related to their motivations, beliefs, values and attitudes towards COVID-19. A multinomial logistic regression model assessed the likelihood of participants being associated with each diffusion category (with the significance level set at p<0.05). Results: The final sample included 2131 respondents. Late adopters were significantly more likely to identify as non-white, live in rural locations and receive vaccinations at pharmacies. Innovators and early adopters were significantly more likely to get vaccinated in settings other than pharmacies or community centres. Conclusion: A diffusion group-based analysis brought insight into how vaccination strategies could be tailored to reach each diffusion group sooner, particularly late adopters who encounter more barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.